XORTX Pharma Corp. Announces Grant of US Patent for the Treatment of Diabetic Nephropathy

XORTX Pharma Corp. – a company focused on the development of drugs to treat orphan and non-orphan kidney diseases – is pleased to announce the Issuance of a U.S. Patent No. 9,155,740, entitled “COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF HYPERURICEMIA RELATED HEALTH CONSEQUENCES”.
› Read more